About the Primary Vitreoretinal Lymphoma Session
Primary vitreoretinal lymphoma (PVRL) is a rare type of non-Hodgkin lymphoma that affects the eyes, specifically the retina and vitreous. It typically presents as blurred vision, floaters, or loss of vision in one or both eyes. PVRL is challenging to diagnose due to its similarity to other eye conditions. Recent advances in cancer research have highlighted the importance of early detection through improved imaging techniques and molecular analysis of vitreous samples. Treatment often involves a combination of chemotherapy, radiation therapy, and intravitreal injections. However, the prognosis remains guarded, with a high risk of recurrence and potential central nervous system involvement. Ongoing research aims to elucidate the underlying mechanisms of PVRL development and identify novel targeted therapies to improve patient outcomes.
Topics Covered in Primary Vitreoretinal Lymphoma
Uveitis Masquerade
Diagnostic Vitrectomy
Cytokine Ratio Testing
Intravitreal Chemotherapy
Ocular Radiotherapy
CNS Progression
Related Scientific Sessions at CIOC 2027
Why Attend the Primary Vitreoretinal Lymphoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Primary Vitreoretinal Lymphoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Primary Vitreoretinal Lymphoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Primary Vitreoretinal Lymphoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Primary Vitreoretinal Lymphoma Conference 2027 — FAQs
What is the Primary Vitreoretinal Lymphoma track at CIOC 2027?
The Primary Vitreoretinal Lymphoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Primary Vitreoretinal Lymphoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Primary Vitreoretinal Lymphoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Primary Vitreoretinal Lymphoma are all welcome — whether presenting or attending.
Can I present my research in the Primary Vitreoretinal Lymphoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Primary Vitreoretinal Lymphoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Primary Vitreoretinal Lymphoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.